MedCognetics, Inc

MedCognetics, Inc. is a healthcare AI company specializing in breast cancer detection and diagnostic assistance. The company develops AI-powered solutions designed to augment radiologist workflows in mammography screening, with a focus on improving early breast cancer detection and reducing radiologist burnout. MedCognetics' primary product, CogNet AI-MT+, received FDA clearance and is designed to triage mammography cases by flagging suspicious findings, enabling radiologists to prioritize high-risk cases and improve diagnostic efficiency. The platform addresses critical clinical needs including radiologist shortages, heavy workloads, and prolonged work hours in breast imaging departments. MedCognetics emphasizes development of unbiased AI algorithms through sourcing diverse patient datasets globally, reflecting a commitment to equitable performance across diverse populations. The company partners with leading academic and medical institutions including UT Dallas, UT Southwestern Medical Center, and specialized radiology organizations, supporting clinical validation and deployment. The solution is positioned for use in resource-constrained regions where radiologist availability cannot meet screening demand, as well as in established healthcare systems seeking to enhance diagnostic accuracy and operational efficiency.